G. Kenet Et Al. , "Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial," Blood , vol.143, no.22, pp.2256-2269, 2024
Kenet, G. Et Al. 2024. Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood , vol.143, no.22 , 2256-2269.
Kenet, G., Nolan, B., ZÜLFİKAR, O. B., Antmen, B., Kampmann, P., Matsushita, T., ... You, C.(2024). Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial. Blood , vol.143, no.22, 2256-2269.
Kenet, Gili Et Al. "Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial," Blood , vol.143, no.22, 2256-2269, 2024
Kenet, Gili Et Al. "Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial." Blood , vol.143, no.22, pp.2256-2269, 2024
Kenet, G. Et Al. (2024) . "Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial." Blood , vol.143, no.22, pp.2256-2269.
@article{article, author={Gili Kenet Et Al. }, title={Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial}, journal={Blood}, year=2024, pages={2256-2269} }